Additional file 1: Table S1

Slides:



Advertisements
Similar presentations
Approach to a patient with jaundice
Advertisements

Liver Function Tests (LFTs)
LFT Workshop Ostadrahimi MD,PhD 31 اردیبهشت ماه 1394.
Iva Pitner Mentor: A. Žmegač Horvat
HEPATOPANCREATOBILIARY Tom Drake and Fran Young. THE BILIRUBIN CYCLE.
Approach to medical liver biopsies Dr Behrang Mozayani Consultant Histopathologist Southmead hospital Bristol.
Hepatic Function Tests CMS approved Hepatic Function Panel Total protein Albumin AST ALT ALP Total Bilirubin Direct bilirubin.
Significance of Liver Function Tests
Table of Contents Decision-Making How do the decisions of today influence us later? Why is it important to be aware of diseases? Diseases in Karachi What.
Liver Function Tests. Tests Based on Detoxification and Excretory Functions.
Other causes of Cirrhosis: Genetic eg. Wilson's Disease, Hemochromatosis Autoimmune eg. Autoimmune Hepatitis, Primary Biliary Cirrhosis, Primary Sclerosing.
Evaluating the Patient With Abnormal Liver Tests-3 פרופ ' צבי אקרמן מבית חולים הדסה הר הצופים.
1 Scenario 13.1 Major Burn. 2 Chest X-ray 3 Post-intubation Chest X-ray Preliminary Read: Endotracheal tube in good position. No pneumothorax or infiltrates.
Differential Diagnosis of Alkaline Phosphatase B 陳建佑.
Complications of Liver Cirrhosis
Liver Seminar for Health Plan Case Managers September 23, 2008 October 2, 2008.
Liver function Tests What are liver tests? Liver tests (LTs) are blood tests used to assess the general state of the liver or biliary system. Few of these.
Steve Bradley Chief Medical Resident, HMC Inpatient Services.
Liver function test Ross Stringer. Synthetic function Albumin & clotting (INR/PT, APTT) Hepatocellular damage AST (aspartate aminotransferase) & ALT (alanine.
Anatomy of the hepatic structure Physiology of the liver.
Budesonide induces remission more effectively than Prednisone in a controlled trial of patients with Autoimmune Hepatitis GASTROENTEROLOGY 2010;139:1198–1206.
M. Browning, M.D. ‘77.  600,000 cases globally  Most common in Eastern Asia  40,000 cases USA  Associated with cirrhosis, chronic liver.
OrganNumber waiting list Dec 08Number Transplant 07/08 Kidney Liver Pancreas83224 Heart Lung Total10,
Kris V. Kowdley, Patricia Belt, Laura A. Wilson, Matthew M. Yeh, Brent A. Neuschwander-Tetri, Naga Chalasani, Arun J. Sanyal, and James E. Nelson ; for.
Liver Function Tests (LFTs)
Recurrent hepatitis with Halogenated Anesthetics
Liver Function Tests (LFTs)
Interpretation of Liver Function Test
INVESTIGATION OF HEPATOBILIARY DISEASE
Varun Kesar M. B. B. S1, Joseph A. Odin M. D, Ph
ACUTE VIRAL HEPATITIS CLINICAL PRESENTATION. DIGNOSIS.
SMOKING AND HISTOLOGICAL STAGE OF CHRONIC VIRAL HEPATITIS
History 24 Year old woman 6 Months of age “severe cholangitis’’ emergently decompressed via cholecystostomy tube choledochal cyst noted Definitive surgery:
Liver Function Tests.
The typical course of acute and chronic hepatitis C
Kirsten Boonstra, Ulrich Beuers, Cyriel Y. Ponsioen 
Hepatopancreatobiliary
Chronic hepatitis C infection
ACUTE VIRAL HEPATITIS CLINICAL PRESENTATION. DIGNOSIS.
Acetaminophen induced Acute Liver Failure
Table 1. Laboratory Data on Admission
Acute viral hepatitis. Acute viral hepatitis is most commonly characterized by lymphocyte predominant inflammatory infiltrates and foci of hepatocyte injury.
Underwriting Screening Liver Test Abnormalities:
Primary biliary cirrhosis, cirrhotic stage
EUROPEAN LIVER TRANSPLANT REGISTRY
Figure 7 Management algorithm for patients with ACLF
Nonalcoholic steatohepatitis
Hepatic Function Tests
Session 4: Expanded indications for bedaquiline and delamanid
Figure 1 Proposed algorithm for the management
Figure 1 Definition and concept of ACLF
Primary biliary cirrhosis, AMA negative
Primary Biliary Cholangitis
Volume 69, Issue 2, Pages (August 2018)
Primary Biliary Cholangitis
Targeting the FXR Nuclear Receptor to Treat Liver Disease
Scenario 13.2 Polytrauma.
Pretransplantation Liver Function Impacts on the Outcome of Allogeneic Hematopoietic Stem Cell Transplantation: A Study of 455 Patients  Pere Barba, José.
Abstracts from Around the World
Volume 151, Issue 6, Pages (December 2016)
Gastroenterology & Nutrition Block Biochemistry Department
Volume 141, Issue 4, Pages (October 2011)
Volume 140, Issue 1, Pages (January 2011)
LFTs and Bloods Laz.
Patient factors that increase risk for drug-induced nephrotoxicity.
Comparison of the Biochemical Responses between TAF and TDF in CHB
Supplementary table 1 Supplementary table 1. Serum biochemistry data and hepatic lipid profiles after drinking water or 20% ethanol for 4 weeks Parameters.
Public Health Policies and Alcohol-related Liver Disease
Fig. 4: Schematic, initial diagnostic algorithm for a patient presenting with mild aminotransferase abnormality. Fig. 4: Schematic, initial diagnostic.
Presentation transcript:

Additional file 1: Table S1 Additional file 1: Table S1. Characteristics of patients with other liver diseases DILI PBC AHB CHC NASH VH Age (yr) 45.7 ± 15.9 59.7 ± 8.4 40.0 ± 17.9 65.5 ± 19.5 54.5 ± 11.2 22.8 ± 2.7 Gender(male/female) 6:13 4:16 6:2 4:4 2:8 2:3 ALT (U/l) 1117.7 ± 1070.9 53.8 ± 39.2 1523.4 ± 1016.9 48.9 ± 25.0 94.5 ± 90.3 771.8 ± 801.8 ALP (U/l) 663.1 ± 266.1 570.9 ± 415.7 580.5 ± 175.3 268.2 ± 102.7 252.7 ± 77.1 601.2 ± 149.1 Alb (g/dl) 3.3 ± 0.5 4.0 ± 0.4 3.7 ± 0.8 3.9 ± 0.2 4.3 ± 0.5 3.9 ± 0.4 TB (mg/dl) 10.4 ± 8.9 0.9 ± 0.7 7.0 ± 6.8 0.9 ± 0.3 0.9 ± 0.2 1.2 ± 0.9 PT (%) 76.3 ± 31.6 99.1 ± 16.8 79.5 ± 21.2 98.0 ± 11.8 105.9 ± 16.0 88.9 ± 13.9 PLT (x104/μl) 20.8 ± 10.1 18.9 ± 6.8 23.2 ± 9.6 13.7 ± 1.9 19.3 ± 6.0 16.6 ± 1.6 IgG (mg/dl) 1340.4 ± 379.6 1828.9 ± 553.6 1891.5 ± 892.9 2370.7 ± 748.6 1633.0 ± 347.3 1458.0 ± 375.9 ANA(median) - 160 80 DILI drug-induced liver injury, PBC primary biliary cholangitis, AHB acute hepatitis B, CHC chronic hepatitis C, NASH nonalcoholic steatohepatitis, VH viral hepatitis